Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of AMDHD1 mRNA] | CTD | PMID:31150632 | 1-naphthyl isothiocyanate | decreases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of AMDHD1 mRNA | CTD | PMID:30723492 | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of AMDHD1 mRNA | CTD | PMID:32145629 | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of AMDHD1 mRNA | CTD | PMID:35192832 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | AMDHD1 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of AMDHD1 mRNA | CTD | PMID:20106945 and PMID:21632981 | 2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one | decreases expression | ISO | Amdhd1 (Mus musculus) | 6480464 | Itraconazole results in decreased expression of AMDHD1 mRNA | CTD | PMID:31099283 | 2-hydroxypropanoic acid | increases expression | ISO | AMDHD1 (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of AMDHD1 mRNA | CTD | PMID:30851411 | aflatoxin B1 | decreases expression | ISO | Amdhd1 (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of AMDHD1 mRNA | CTD | PMID:19770486 | aflatoxin B1 | decreases expression | ISO | AMDHD1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of AMDHD1 mRNA | CTD | PMID:27153756 | aflatoxin B1 | decreases methylation | ISO | AMDHD1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of AMDHD1 gene | CTD | PMID:27153756 | antirheumatic drug | decreases expression | ISO | AMDHD1 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of AMDHD1 mRNA | CTD | PMID:24449571 | aristolochic acid A | increases expression | ISO | AMDHD1 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of AMDHD1 mRNA | CTD | PMID:33212167 | Benoxacor | increases expression | ISO | Amdhd1 (Mus musculus) | 6480464 | benoxacor results in increased expression of AMDHD1 mRNA | CTD | PMID:34850242 | benzo[a]pyrene | decreases expression | ISO | Amdhd1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of AMDHD1 mRNA | CTD | PMID:21715664 | benzo[a]pyrene | increases methylation | ISO | AMDHD1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of AMDHD1 3' UTR | CTD | PMID:27901495 | benzo[a]pyrene | decreases expression | ISO | AMDHD1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of AMDHD1 mRNA | CTD | PMID:21632981 and PMID:26238291 | Benzo[k]fluoranthene | decreases expression | ISO | Amdhd1 (Mus musculus) | 6480464 | benzo(k)fluoranthene results in decreased expression of AMDHD1 mRNA | CTD | PMID:26377693 | bis(2-ethylhexyl) phthalate | decreases expression | ISO | AMDHD1 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in decreased expression of AMDHD1 mRNA | CTD | PMID:31163220 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of AMDHD1 mRNA | CTD | PMID:30903817 and PMID:32145629 | bisphenol A | increases methylation | ISO | AMDHD1 (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of AMDHD1 gene | CTD | PMID:31601247 | bisphenol A | multiple interactions | ISO | AMDHD1 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of AMDHD1 gene | CTD | PMID:31601247 | bisphenol A | decreases expression | ISO | Amdhd1 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of AMDHD1 mRNA | CTD | PMID:33221593 | bisphenol A | increases expression | ISO | Amdhd1 (Mus musculus) | 6480464 | bisphenol A results in increased expression of AMDHD1 mRNA | CTD | PMID:30245210 | carbon nanotube | decreases expression | ISO | Amdhd1 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25620056 | chlorpyrifos | decreases expression | ISO | Amdhd1 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of AMDHD1 mRNA | CTD | PMID:37019170 | copper(II) sulfate | decreases expression | ISO | AMDHD1 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of AMDHD1 mRNA | CTD | PMID:19549813 | cyclosporin A | decreases expression | ISO | AMDHD1 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of AMDHD1 mRNA | CTD | PMID:20106945 more ... | dorsomorphin | multiple interactions | ISO | AMDHD1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AMDHD1 mRNA | CTD | PMID:27188386 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of AMDHD1 mRNA | CTD | PMID:29391264 | fenthion | decreases expression | ISO | Amdhd1 (Mus musculus) | 6480464 | Fenthion results in decreased expression of AMDHD1 mRNA | CTD | PMID:34813904 | fulvestrant | multiple interactions | ISO | AMDHD1 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of AMDHD1 gene | CTD | PMID:31601247 | indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of AMDHD1 mRNA | CTD | PMID:21396975 | inulin | multiple interactions | ISO | Amdhd1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of AMDHD1 mRNA | CTD | PMID:36331819 | itraconazole | decreases expression | ISO | Amdhd1 (Mus musculus) | 6480464 | Itraconazole results in decreased expression of AMDHD1 mRNA | CTD | PMID:31099283 | ketoconazole | decreases expression | ISO | Amdhd1 (Mus musculus) | 6480464 | Ketoconazole results in decreased expression of AMDHD1 mRNA | CTD | PMID:31099283 | methidathion | affects expression | ISO | Amdhd1 (Mus musculus) | 6480464 | methidathion affects the expression of AMDHD1 mRNA | CTD | PMID:34813904 | methylmercury chloride | decreases expression | ISO | AMDHD1 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of AMDHD1 mRNA | CTD | PMID:28001369 | nitrofen | increases expression | EXP | | 6480464 | nitrofen results in increased expression of AMDHD1 mRNA | CTD | PMID:33484710 | paracetamol | affects expression | ISO | Amdhd1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of AMDHD1 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of AMDHD1 mRNA | CTD | PMID:30723492 | paracetamol | decreases expression | ISO | AMDHD1 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of AMDHD1 mRNA | CTD | PMID:29067470 | perfluorononanoic acid | decreases expression | ISO | AMDHD1 (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of AMDHD1 mRNA | CTD | PMID:32588087 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Amdhd1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of AMDHD1 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of AMDHD1 mRNA | CTD | PMID:36331819 | phenformin | increases expression | EXP | | 6480464 | Phenformin results in increased expression of AMDHD1 mRNA | CTD | PMID:31324951 | phenobarbital | decreases expression | ISO | Amdhd1 (Mus musculus) | 6480464 | Phenobarbital results in decreased expression of AMDHD1 mRNA | CTD | PMID:19482888 | phenobarbital | multiple interactions | ISO | Amdhd1 (Mus musculus) | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of AMDHD1 mRNA] | CTD | PMID:19482888 | pirinixic acid | decreases expression | ISO | Amdhd1 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of AMDHD1 mRNA | CTD | PMID:23811191 | propiconazole | decreases expression | ISO | Amdhd1 (Mus musculus) | 6480464 | propiconazole results in decreased expression of AMDHD1 mRNA | CTD | PMID:21278054 | quercetin | decreases expression | ISO | AMDHD1 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of AMDHD1 mRNA | CTD | PMID:21632981 | quinolin-8-ol | decreases expression | ISO | AMDHD1 (Homo sapiens) | 6480464 | Oxyquinoline results in decreased expression of AMDHD1 mRNA | CTD | PMID:21632981 | rac-lactic acid | increases expression | ISO | AMDHD1 (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of AMDHD1 mRNA | CTD | PMID:30851411 | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of AMDHD1 mRNA | CTD | PMID:28374803 | SB 431542 | multiple interactions | ISO | AMDHD1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AMDHD1 mRNA | CTD | PMID:27188386 | silicon dioxide | decreases expression | ISO | Amdhd1 (Mus musculus) | 6480464 | Silicon Dioxide results in decreased expression of AMDHD1 mRNA | CTD | PMID:23221170 | silver atom | increases expression | ISO | Amdhd1 (Mus musculus) | 6480464 | Silver results in increased expression of AMDHD1 mRNA | CTD | PMID:27131904 | silver(0) | increases expression | ISO | Amdhd1 (Mus musculus) | 6480464 | Silver results in increased expression of AMDHD1 mRNA | CTD | PMID:27131904 | sodium arsenite | increases expression | ISO | Amdhd1 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of AMDHD1 protein | CTD | PMID:29044176 | sodium arsenite | decreases expression | ISO | Amdhd1 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of AMDHD1 mRNA | CTD | PMID:37682722 | temozolomide | increases expression | ISO | AMDHD1 (Homo sapiens) | 6480464 | Temozolomide results in increased expression of AMDHD1 mRNA | CTD | PMID:31758290 | tetrachloromethane | decreases expression | ISO | Amdhd1 (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of AMDHD1 mRNA | CTD | PMID:27339419 and PMID:31919559 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of AMDHD1 mRNA | CTD | PMID:31150632 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of AMDHD1 mRNA] | CTD | PMID:31150632 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of AMDHD1 mRNA | CTD | PMID:34492290 | trichostatin A | decreases expression | ISO | AMDHD1 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of AMDHD1 mRNA | CTD | PMID:24935251 and PMID:26272509 | troglitazone | decreases expression | ISO | Amdhd1 (Mus musculus) | 6480464 | troglitazone results in decreased expression of AMDHD1 mRNA | CTD | PMID:28973697 | troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of AMDHD1 protein | CTD | PMID:21315101 | valproic acid | affects expression | ISO | AMDHD1 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of AMDHD1 mRNA | CTD | PMID:25979313 | valproic acid | increases expression | ISO | AMDHD1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of AMDHD1 mRNA | CTD | PMID:23179753 more ... | valproic acid | decreases expression | ISO | AMDHD1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of AMDHD1 mRNA | CTD | PMID:23179753 and PMID:26272509 | valproic acid | multiple interactions | ISO | AMDHD1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AMDHD1 mRNA | CTD | PMID:27188386 | |